Description: XWELL, Inc. (Nasdaq: XWEL) is a leading global health and wellness holding company operating four brands: XpresCheck®, XpresSpa®, Treat™ and HyperPointe. XpresSpa is a leading airport retailer of wellness services and related products, with 26 locations in 13 airports globally. Treat is a travel health and wellness brand, the first fully integrated in-airport spa and wellness concept, providing medical services, state-of-the-art testing, and a holistic approach to physical and mental well-being at three domestic airport locations. XpresCheck is a leading provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo, conducting biosurveillance monitoring in its airport locations to identify existing and new SARS-CoV-2 variants. HyperPointe is a leading digital healthcare and data analytics relationship company serving the global healthcare industry.
Home Page: www.xwell.com
XWEL Technical Analysis
254 West 31st Street
New York,
NY
10001
United States
Phone:
212 309 7549
Officers
| Name | Title |
|---|---|
| Mr. Scott R. Milford | Pres, CEO & Director |
| Mr. Omar A. Haynes | Interim Chief Financial Officer |
| Mr. David Kohel | Chief Technology Officer |
| Ms. Cara Soffer | Sr. VP & Gen. Counsel |
| Pablo Henderson | Chief Marketing Officer |
| Mr. Ezra Ernst | Chief Exec. Officer of XpresTest, Inc. |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.755 |
| Price-to-Sales TTM: | 0.4819 |
| IPO Date: | 2018-01-05 |
| Fiscal Year End: | December |
| Full Time Employees: | 363 |